A recent meta-analysis from the National Institute of Health identified a FANCD1/BRCA2 double mutated subset that showed a severe impairment of DNA damage response resulting in a cumulative incidence of cancer of 97% by age 7 years, including AML [25,27]. The gene discussed is BRCA2; the disease is acute myeloid leukemia.